Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06736730 · ClinicalTrials.gov registry record · NA
Mississippi Violence Injury Prevention (VIP) Program
A NA study, sponsored by University of Mississippi Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT06736730: Clinical Trial NA study, sponsored by University of Mississippi Medical Center.
NCT06736730 is a NA study that has not yet begun recruiting, run by University of Mississippi Medical Center. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06736730, a NA study, has not yet begun recruiting, sponsored by University of Mississippi Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
This clinical trial is designed to evaluate the effectiveness of three interventions aimed at preventing violence and supporting those affected by it. Over next three years, the impact of these interventions on key areas will be measured, including the incidence of firearm injuries, the recovery of victims, the occurrence of retaliation and re-injury, and health economics. The interventions are developed based on data collected from a comprehensive needs assessment, community summit, retrospective medical chart reviews, and focus group sessions. The defined interventions are as follows: Intervention A - Integration of an existing community-based intervention program with Hospital services intervention B - Unrestricted Cash Assistance Intervention C - Mobile Community Support Services Additionally, the investigators will implement a detailed violence-focused survey for firearm survivors at the time of study enrollment. Follow-up is planned at 3,6 and 12 months. The results of this trial (including analyses of firearm injury rates, recovery outcomes, retaliation/re-injury occurrences, and economic data) will be shared with the affected communities and stakeholders to promote ongoing improvement and support.
Primary Outcome
The data will be collected from hospital and JPD records. Excluding self-inflicted such as suicide or adjudicated to be accidental/unintentional.
Interventions
- BEHAVIORAL Hospital-Linked Violence Intervention Program
- BEHAVIORAL Mobile Community Event Support
- BEHAVIORAL Unrestricted Cash Assistance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What is known before NCT06736730 opens enrollment
NCT06736730 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 3 interventions - of which Hospital-Linked Violence Intervention Program is the first listed.
NCT06736730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06736730 about?
NCT06736730 is a clinical study titled "Mississippi Violence Injury Prevention (VIP) Program". This clinical trial is designed to evaluate the effectiveness of three interventions aimed at preventing violence and supporting those affected by it. Over next three years, the impact of these interventions on key areas will be measured, including the incidence of firearm injuries, the recovery of ...
What is the current status of trial NCT06736730?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-03-01. Estimated completion is 2028-06-30.
What interventions are being tested in trial NCT06736730?
The interventions under investigation include: Hospital-Linked Violence Intervention Program (BEHAVIORAL), Mobile Community Event Support (BEHAVIORAL), Unrestricted Cash Assistance (BEHAVIORAL).
Who is sponsoring clinical trial NCT06736730?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06736730's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI